AA-PEG	Aminoethylanisamide-PEG
AVPC	Aggressive variant prostate cancer
BBB	Blood–brain barrier
BC	Breast cancer
CAF	Cancer-associated fibroblast
CTCs	Circulating tumor cells
CtDNA	Circulating tumor DNA
DC	Dendritic cells
DX	Doxorubicin
ECM	Extracellular matrix
EFS	Early feasibility study
EGFR	Epidermal growth factor receptor
EMA	European medicines agency
EMT	Epithelial–mesenchymal transition
EPCAM	Epithelial cellular adhesion molecule
ER	Endoplasmic reticulum
ESCRT	Endosome sorting complex required for transport
EVs	Extracellular vesicles
FasR	Fas receptor
FDA	Food and drug administration
GEM	Gemcitabine
GSTP1	Glutathione S-transferase P1
HC	Hepatocellular carcinoma
Her	Human epidermal growth factor receptor
HIF-1 α	Hypoxia-inducible factor-1 α
ILVs	Intraluminal vesicles
ISEV	International Society for Extracellular Vesicles
LEVs	Large extracellular vesicles
LLC	Lewis lung carcinoma
MAGE3	Melanoma antigen 3
mCTX	Metronomic cyclophosphamide
MDCK	Madin–Darby canine kidney
MDSC	Myeloid-derived suppressor cell
MenSC	Menstrual mesenchymal stem cell
MHC	Major histocompatibility complex
MLC	Myosin light chain
MM	Multiple myeloma
MSCs	Mesenchymal stromal cells
MVBs	Multivesicular bodies
MVs	Microvesicles
NK	Natural killer
OS	Overall survival
PDAC	Pancreatic ductal adenocarcinoma
PEG	Polyethylene glycol
piRNAs	Piwi-interacting RNAs
PTX	Paclitaxel
RAB	RAS-related protein
RBPs	RNA-binding proteins
RFXAP	Regulatory factor X-associated protein
TAA	Tumor-associated antigen
TCF21	Transcription factor 21
TEM	Tetraspanins-enriched domains
tEVs	Tumor extracellular vesicles
TGF-β	Transforming growth factor-β
TGN	Trans-Golgi network
TLR2	Toll-like receptor 2
TME	Tumor microenvironment
TNFR1	Tumor necrosis factor receptor 1
VEGF	Vascular endothelial growth factor